NCT00214838View on ClinicalTrials.gov

An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

March 31, 2007

Conditions
Advanced Cancer
Interventions
DRUG

Atiprimod

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Callisto Pharmaceuticals

INDUSTRY